EBITDA: Income before interest, taxes, depreciation and amortization.
Third Harmonic Bio, Inc. (THRD) had EBITDA of $-58.82M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-45.47M |
|
-- |
|
-- |
|
$58.87M |
|
$-58.87M |
|
$13.40M |
|
$-45.47M |
|
$-45.47M |
|
$-45.47M |
|
$-45.47M |
|
$-45.47M |
|
$-45.47M |
|
$-58.87M |
|
|
EBITDA |
$-58.82M |
41.73M |
|
41.73M |
|
$-1.09 |
|
$-1.09 |
|
| Balance Sheet Financials | |
$290.54M |
|
$0.13M |
|
$4.07M |
|
$294.61M |
|
$7.11M |
|
-- |
|
$2.35M |
|
$9.46M |
|
$285.15M |
|
$285.15M |
|
$285.15M |
|
44.86M |
|
| Cash Flow Statement Financials | |
$-34.50M |
|
$-0.01M |
|
$50.51M |
|
$269.52M |
|
$285.52M |
|
$15.99M |
|
$11.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
40.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.95% |
|
-15.95% |
|
-15.43% |
|
-15.95% |
|
$6.36 |
|
$-0.83 |
|
$-0.83 |
|